Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
QGEN.N - Qiagen NV
Qiagen NV at Citi Global Healthcare Conference
Dec 02, 2025 / 02:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Time, then kaya Symphony Connect, like you brought up earlier, this has been, optimized even more for liquid biopsy applications, but that's primarily a clinical market even though you have some research customers for symphony, but that's kind of the split of the markets. Remember, in terms of growth going forward, the par sales next year, 40 million will come on top of the sample prep, so it's probably a good 2 points of growth for the group, even more for our sample prep number. And then these instruments will start to kick in in the second half of 26 in terms of incremental growth.
--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------------------------
Trustpilot
